Physician profile
Amanda Doris Mitchell
NPI 1073745808
$666.86
in general payments reported to CMS, 2019-2025
9 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2023: $336 · 2024: $25.22 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.97 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $242.89 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $219.71 | 2023 | Reblozyl, Pomalyst |
| Abbvie INC. | $57.91 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $32.47 | 2025 | Libtayo |
| Novartis Pharmaceuticals Corporation | $30.02 | 2025 | |
| Beone Medicines USA, INC. | $28.15 | 2025 | Brukinsa |
| Janssen Pharmaceuticals, INC | $25.22 | 2024 | Invega Sustenna |
| Gilead Sciences, INC. | $16.32 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.17 | 2025 | Calquence |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.